| (+)-Licarin |
|
|
|
|
|
| (+)-Theta-cypermethrin |
|
|
|
|
|
| (-)-Syringaresinol |
|
|
|
|
99.93% |
| (−)-Myrtenal |
|
|
|
|
98.87% |
| (22S,23S)-Homobrassinolide |
|
|
|
|
99.80% |
| (2S)-OMPT |
|
|
|
|
|
| (2S)-OMPT triethylamine, in ethanol:chloroform (1:1), 98% |
|
|
|
|
99.0% |
| (E)-Akt inhibitor-IV |
|
|
|
|
98.63% |
| (E/Z)-Afatinib |
|
|
|
|
99.98% |
| (R)-Capivasertib |
|
|
|
|
99.56% |
| (R)-CCG-1423 |
|
|
|
|
|
| (Rac)-AAA |
|
|
|
|
|
| (rac)-AG-205 |
|
|
|
|
|
| (Rac)-Chem-0199 |
|
|
|
|
99.81% |
| (Z)-Guggulsterone |
|
|
|
|
99.41% |
| (±)-10-Gingerol |
|
|
|
|
|
| 1,3,5-Tricaffeoylquinic acid |
|
|
|
|
|
| 1,3-Dicaffeoylquinic acid |
|
|
|
|
99.90% |
| 1-Monopalmitin |
|
|
|
|
99.89% |
| 1-Monopalmitin-d31 |
|
|
|
|
|
| 10-DEBC hydrochloride |
|
|
|
|
99.82% |
| 10-Gingerol |
|
|
|
|
99.48% |
| 15(S)-HPETE |
|
|
|
|
97.32% |
| 19-epi-Scholaricine |
|
|
|
|
99.14% |
| 2,6-Dimethoxy-1,4-benzoquinone |
|
|
|
|
98.72% |
| 2-Chlorophenoxazine |
|
|
|
|
|
| 2-Aminonicotinaldehyde |
|
|
|
|
99.85% |
| 20(R)-Ginsenoside Rh2 |
|
|
|
|
99.84% |
| 20-5,14-HEDE |
|
|
|
|
98.34% |
| 20-5,14-HEDE-d2 |
|
|
|
|
|
| 20-5,14-HEDE-d2-1 |
|
|
|
|
|
| 20-5,14-HEDE-d2-2 |
|
|
|
|
|
| 22-(4′-py)-JA |
|
|
|
|
|
| 24-Methylenecycloartanyl ferulate |
|
|
|
|
98.53% |
| Alisol A 24-acetate |
|
|
|
|
98.0% |
| 25(R,S)-Ruscogenin |
|
|
|
|
99.83% |
| 3′,4′,7-Trihydroxyflavone |
|
|
|
|
99.04% |
| 3'-Methoxy-4'-nitroflavone |
|
|
|
|
|
| 3,4,5-Tricaffeoylquinic acid |
|
|
|
|
98.15% |
| 3CAI |
|
|
|
|
98.32% |
| 4′-Hydroxywogonin |
|
|
|
|
98.22% |
| 4,4'-Sulfonyldiphenol-d8 |
|
|
|
|
99.21% |
| 4-Hydroxychalcone |
|
|
|
|
99.29% |
| 4-Vinylcyclohexene dioxide |
|
|
|
|
98.57% |
| 4-Methylbenzylidene camphor |
|
|
|
|
99.87% |
| 5,4'-Dihydroxy-6,8-dimethoxy-7-O-rhamnosyl flavone |
|
|
|
|
|
| 6'-BPANeuGc |
|
|
|
|
|
| 6'-Sialyllactose |
|
|
|
|
99.60% |
| 6'-Sialyllactose sodium |
|
|
|
|
98.05% |
| 6,8-Diprenylorobol |
|
|
|
|
98.40% |
| 6-Hydroxyflavone |
|
|
|
|
99.92% |
| 6-Methoxydihydrosanguinarine |
|
|
|
|
99.88% |
| 6-Methoxydihydrosanguinarine hydrochloride |
|
|
|
|
|
| 6-O-Isobutyrylbritannilactone |
|
|
|
|
98.34% |
| 6-Demethoxytangeretin |
|
|
|
|
99.37% |
| 7,4'-Dimethoxy-3-hydroxyflavone |
|
|
|
|
|
| 7-Methoxy-1-tetralone |
|
|
|
|
99.70% |
| 7α-Hydroxycholesterol |
|
|
|
|
99.99% |
| 8-Gingerol |
|
|
|
|
99.82% |
| 8-O-Acetylharpagide |
|
|
|
|
99.75% |
| 8-Prenylnaringenin |
|
|
|
|
99.63% |
| 8-Aminoadenosine |
|
|
|
|
99.05% |
| Sexangularetin 3-sophoroside |
|
|
|
|
|
| 9(10)-Nitrooleate |
|
|
|
|
|
| 9(R)-PAHSA |
|
|
|
|
|
| A-674563 |
|
|
|
|
99.78% |
| A-674563 hydrochloride |
|
|
|
|
99.61% |
| A2073 |
|
|
|
|
|
| AC-P19M |
|
|
|
|
|
| Acetyl-Exenatide |
|
|
|
|
|
| Ack1 inhibitor 1 |
|
|
|
|
|
| Adropin (34-76) (human, mouse, rat) |
|
|
|
|
98.23% |
| Afatinib oxalate |
|
|
|
|
|
| Afuresertib |
|
|
|
|
99.53% |
| Afuresertib hydrochloride |
|
|
|
|
99.95% |
| AG01 |
|
|
|
|
95.10% |
| AKT inhibitor IV |
|
|
|
|
99.4% |
| AKT inhibitor VIII |
|
|
|
|
98.36% |
| AKT Kinase Inhibitor |
|
|
|
|
99.92% |
| AKT Kinase Inhibitor hydrochloride |
|
|
|
|
99.39% |
| AKT-IN-1 |
|
|
|
|
98.41% |
| AKT-IN-10 |
|
|
|
|
|
| AKT-IN-11 |
|
|
|
|
|
| AKT-IN-12 |
|
|
|
|
|
| AKT-IN-14 |
|
|
|
|
|
| AKT-IN-14 free base |
|
|
|
|
|
| AKT-IN-17 |
|
|
|
|
|
| AKT-IN-18 |
|
|
|
|
|
| AKT-IN-2 |
|
|
|
|
|
| AKT-IN-20 |
|
|
|
|
|
| AKT-IN-21 |
|
|
|
|
|
| AKT-IN-22 |
|
|
|
|
|
| AKT-IN-23 |
|
|
|
|
98.96% |
| AKT-IN-24 |
|
|
|
|
|
| AKT-IN-25 |
|
|
|
|
|
| AKT-IN-26 |
|
|
|
|
|
| AKT-IN-27 |
|
|
|
|
|
| AKT-IN-28 |
|
|
|
|
|
| AKT-IN-3 |
|
|
|
|
98.12% |
| AKT-IN-5 |
|
|
|
|
|
| AKT-IN-6 |
|
|
|
|
99.08% |
| AKT-IN-7 |
|
|
|
|
|
| AKT-IN-8 |
|
|
|
|
|
| AKT-IN-9 |
|
|
|
|
|
| Akt/mTOR-IN-1 |
|
|
|
|
|
| Akt/NF-κB/JNK-IN-1 |
|
|
|
|
|
| Akt/SKG Substrate Peptide |
|
|
|
|
|
| Akt/SKG Substrate Peptide TFA |
|
|
|
|
|
| AKT1 E17K Recombinant Human Active Protein Kinase |
|
|
|
|
|
| AKT1 Human Pre-designed siRNA Set A |
|
|
|
|
|
| Akt1 Mouse Pre-designed siRNA Set A |
|
|
|
|
|
| Akt1 Rat Pre-designed siRNA Set A |
|
|
|
|
|
| Akt1&PKA-IN-1 |
|
|
|
|
|
| Akt1&PKA-IN-2 |
|
|
|
|
|
| Akt1-IN-1 |
|
|
|
|
99.77% |
| AKT1-IN-10 |
|
|
|
|
|
| AKT1-IN-11 |
|
|
|
|
|
| AKT1-IN-12 |
|
|
|
|
|
| AKT1-IN-13 |
|
|
|
|
|
| Akt1-IN-2 |
|
|
|
|
|
| Akt1-IN-3 |
|
|
|
|
|
| Akt1-IN-4 |
|
|
|
|
|
| Akt1-IN-5 |
|
|
|
|
|
| Akt1-IN-6 |
|
|
|
|
|
| Akt1-IN-7 |
|
|
|
|
|
| Akt1-IN-8 |
|
|
|
|
|
| AKT1-IN-9 |
|
|
|
|
99.79% |
| Akt1/Akt2-IN-1 |
|
|
|
|
99.30% |
| Akt1/Akt2-IN-2 |
|
|
|
|
96.01% |
| AKT2 Human Pre-designed siRNA Set A |
|
|
|
|
|
| Akt2 Mouse Pre-designed siRNA Set A |
|
|
|
|
|
| Akt2 Rat Pre-designed siRNA Set A |
|
|
|
|
|
| Akt3 degrader 1 |
|
|
|
|
95.10% |
| AKT3 Human Pre-designed siRNA Set A |
|
|
|
|
|
| Akt3 ligand-1 |
|
|
|
|
|
| Akt3 Mouse Pre-designed siRNA Set A |
|
|
|
|
|
| Akt3 Rat Pre-designed siRNA Set A |
|
|
|
|
|
| AKTide-2T |
|
|
|
|
|
| AKTide-2T TFA |
|
|
|
|
|
| Albanol B |
|
|
|
|
99.79% |
| Alborixin |
|
|
|
|
|
| ALK-IN-31 |
|
|
|
|
|
| ALK/PI3K/AKT-IN-1 |
|
|
|
|
|
| Alphitolic acid |
|
|
|
|
97.0% |
| ALR2-IN-9 |
|
|
|
|
|
| AM-8508 |
|
|
|
|
|
| AM-9635 |
|
|
|
|
|
| Amsacrine isethionate |
|
|
|
|
|
| Amsacrine lactate |
|
|
|
|
|
| AMT-562 |
|
|
|
|
|
| AMZ30 |
|
|
|
|
99.10% |
| Antcin K |
|
|
|
|
|
| Anti-CD146 Antibody (AA98) |
|
|
|
|
|
| Anti-CD160 Antibody (MAT 302) |
|
|
|
|
|
| Anti-CD220/Insulin Receptor Antibody (IR 83-22) |
|
|
|
|
|
| Anti-Human/Mouse GRP78 Antibody (N88) |
|
|
|
|
|
| Anti-Mouse E-Cadherin/CD324 Antibody (DECMA-1) |
|
|
|
|
|
| Antiangiogenic agent 4 |
|
|
|
|
|
| Anticancer agent 189 |
|
|
|
|
|
| Anticancer agent 235 |
|
|
|
|
|
| Anticancer agent 253 |
|
|
|
|
|
| Anticancer agent 273 |
|
|
|
|
|
| Anticancer agent 308 |
|
|
|
|
|
| Anticancer agent 319 |
|
|
|
|
|
| Antidiabetic agent 6 |
|
|
|
|
99.97% |
| Antihypertensive agent 7 |
|
|
|
|
|
| Antiproliferative agent-57 |
|
|
|
|
|
| Antitumor agent-122 |
|
|
|
|
|
| Antitumor agent-86 |
|
|
|
|
|
| API-1 |
|
|
|
|
99.62% |
| APN/AKT-IN-1 |
|
|
|
|
|
| Apoptosis inducer 35 |
|
|
|
|
|
| Apoptosis inducer 55 |
|
|
|
|
|
| Archexin |
|
|
|
|
|
| Archexin sodium |
|
|
|
|
|
| Archexin sodium scrambled negative control |
|
|
|
|
|
| ARI-1 |
|
|
|
|
99.16% |
| Arteanoflavone |
|
|
|
|
|
| Arundic Acid |
|
|
|
|
98.0% |
| Arvanil |
|
|
|
|
99.1% |
| AS-605240 potassium |
|
|
|
|
|
| AS1938909 |
|
|
|
|
|
| AS1949490 |
|
|
|
|
99.49% |
| ASP3026 |
|
|
|
|
99.88% |
| ASX-173 |
|
|
|
|
98.47% |
| AT-533 |
|
|
|
|
98.38% |
| AT13148 |
|
|
|
|
99.20% |
| AT7867 |
|
|
|
|
99.85% |
| AT7867 dihydrochloride |
|
|
|
|
99.73% |
| AT7867 hydrochloride |
|
|
|
|
|
| Auriculasin |
|
|
|
|
98.54% |
| Autophagy inducer 7 |
|
|
|
|
99.45% |
| Avicin G |
|
|
|
|
|
| AZ14289671 |
|
|
|
|
|
| AZD3409 |
|
|
|
|
|
| Batiraxcept |
|
|
|
|
99.91% |
| BAY 2476568 |
|
|
|
|
99.88% |
| BAY1125976 |
|
|
|
|
99.52% |
| BBO-10203 |
|
|
|
|
99.12% |
| BEPP hydrochloride |
|
|
|
|
99.62% |
| BI-113823 |
|
|
|
|
99.23% |
| BI-4732 |
|
|
|
|
99.30% |
| BI-69A11 |
|
|
|
|
99.09% |
| BIBU1361 |
|
|
|
|
|
| BIBU1361 dihydrochloride |
|
|
|
|
|
| Biotin-AKT1 Recombinant Human Active Protein Kinase |
|
|
|
|
|
| Biotin-AKT2 Recombinant Human Active Protein Kinase |
|
|
|
|
|
| Biotin-AKT3 Recombinant Human Active Protein Kinase |
|
|
|
|
|
| Biotin-Crosstide |
|
|
|
|
|
| Bisphenol F |
|
|
|
|
99.93% |
| Bisphenol F-13C12 |
|
|
|
|
|
| Bisphenol F-13C6 |
|
|
|
|
|
| BJ-2302 |
|
|
|
|
|
| Borussertib |
|
|
|
|
99.18% |
| BPH-628 |
|
|
|
|
|
| BPRCX807 |
|
|
|
|
|
| BRD4/AKT-IN-1 |
|
|
|
|
|
| BRK/PTK6-IN-1 |
|
|
|
|
|
| BSI-001 |
|
|
|
|
|
| Butrin |
|
|
|
|
|
| BV02 |
|
|
|
|
99.75% |
| BYBC-1 |
|
|
|
|
|
| C-Reactive Protein (CRP) (174-185) |
|
|
|
|
99.88% |
| C-VGB3 |
|
|
|
|
|
| CAIX/XII/NAMPT-IN-1 |
|
|
|
|
|
| Cajanol |
|
|
|
|
|
| Calebin A |
|
|
|
|
98.0% |
| Cannflavin B |
|
|
|
|
98.14% |
| Canthin-6-one |
|
|
|
|
99.92% |
| Capivasertib |
|
|
|
|
99.96% |
| Capivasertib-d4 |
|
|
|
|
|
| Catestatin (rat) |
|
|
|
|
|
| CAY10404 |
|
|
|
|
99.40% |
| CAY10526 |
|
|
|
|
99.12% |
| CC-11 |
|
|
|
|
|
| CCT128930 |
|
|
|
|
98.95% |
| CCT128930 hydrochloride |
|
|
|
|
98.97% |
| CCT129254 |
|
|
|
|
|
| CCT365623 hydrochloride |
|
|
|
|
98.07% |
| CDC20/HSP90-IN-1 |
|
|
|
|
|
| CDPPB |
|
|
|
|
98.01% |
| Cenisertib |
|
|
|
|
99.86% |
| Cenisertib benzoate |
|
|
|
|
|
| Ceramide (Egg) |
|
|
|
|
99% |
| Ch-319 |
|
|
|
|
|
| Chem-0199 |
|
|
|
|
|
| Chemerin-9 (149-157) |
|
|
|
|
99.57% |
| Chemerin-9 (149-157) TFA |
|
|
|
|
98.41% |
| Chloramphenicol/BSA |
|
|
|
|
|
| CHNQD-01281 |
|
|
|
|
|
| CHNQD-01426 |
|
|
|
|
|
| CHPG |
|
|
|
|
99.51% |
| CHPG sodium salt |
|
|
|
|
99.57% |
| Chromeceptin |
|
|
|
|
99.80% |
| Chrysomycin A |
|
|
|
|
98.0% |
| Chrysotoxine |
|
|
|
|
99.52% |
| CIB-L43 |
|
|
|
|
99.71% |
| Ciprofloxacin |
|
|
|
|
|
| cis,trans-Germacrone |
|
|
|
|
|
| cis-Trismethoxy resveratrol |
|
|
|
|
99.87% |
| CK2-TN03 |
|
|
|
|
98.02% |
| CK37 |
|
|
|
|
|
| CKD-712 |
|
|
|
|
|
| CMX-2043 |
|
|
|
|
98.80% |
| Coelogin |
|
|
|
|
|
| Coelonin |
|
|
|
|
98.0% |
| COH-19 |
|
|
|
|
|
| Communic acid |
|
|
|
|
|
| COVA208 |
|
|
|
|
|
| Creatine monohydrate |
|
|
|
|
99.98% |
| Creatine-13C monohydrate |
|
|
|
|
|
| Creosol |
|
|
|
|
99.82% |
| Creosol-d4 |
|
|
|
|
|
| CRI9 |
|
|
|
|
|
| Crosstide |
|
|
|
|
98.37% |
| Cryptanoside A |
|
|
|
|
|
| CSF1R-IN-26 |
|
|
|
|
|
| CSF1R-IN-27 |
|
|
|
|
|
| CTX-0294885 |
|
|
|
|
99.43% |
| CTX-0294885 hydrochloride |
|
|
|
|
99.73% |
| Cucurbitacin C |
|
|
|
|
95.0% |
| Cyanidin 3,5-diglucoside chloride |
|
|
|
|
99.44% |
| D-Allose |
|
|
|
|
99.85% |
| D-Allose-13C |
|
|
|
|
|
| D-Allose-13C-1 |
|
|
|
|
|
| D-Allose-13C-2 |
|
|
|
|
|
| d-GLP-2 E33A |
|
|
|
|
|
| D-GsMTx4 |
|
|
|
|
99.44% |
| D-GsMTx4 TFA |
|
|
|
|
99.89% |
| D-myo-Inositol-1,3,4,5,6-pentaphosphate ammonium salt |
|
|
|
|
98% |
| D-myo-Inositol-1,3,4,5,6-pentaphosphate sodium |
|
|
|
|
|
| D927 |
|
|
|
|
99.46% |
| Dammarenediol II |
|
|
|
|
99.81% |
| Daphnoretin |
|
|
|
|
99.83% |
| DB07107 |
|
|
|
|
|
| DCZ3301 |
|
|
|
|
99.73% |
| DDO-6600 |
|
|
|
|
98.19% |
| Degalactotigonin |
|
|
|
|
|
| Dehydrovomifoliol |
|
|
|
|
98.88% |
| Dehydroxy-oridonin-vinyl ester |
|
|
|
|
|
| Deltafluorine |
|
|
|
|
|
| Demethylasterriquinone B1 |
|
|
|
|
98.10% |
| DETD-35 |
|
|
|
|
|
| DFX117 |
|
|
|
|
|
| DHW-208 |
|
|
|
|
|
| DHW-221 |
|
|
|
|
|
| Diosbulbin C |
|
|
|
|
|
| Diphenyl disulfide |
|
|
|
|
99.96% |
| Doxycycline calcium |
|
|
|
|
|
| Doxycycline hydrochloride |
|
|
|
|
|
| Doxycycline-13C,d3 |
|
|
|
|
|
| DTPD-Q |
|
|
|
|
99.68% |
| DZ2002 |
|
|
|
|
99.83% |
| DZX19 |
|
|
|
|
|
| eALM1137 |
|
|
|
|
|
| EEF1A2-IN-1 |
|
|
|
|
|
| Efadirelaxin alfa |
|
|
|
|
|
| EGCG Octaacetate |
|
|
|
|
98.57% |
| EGFR kinase-IN-8 |
|
|
|
|
|
| EGFR-IN-113 |
|
|
|
|
|
| EGFR-IN-120 |
|
|
|
|
|
| EGFR-IN-154 |
|
|
|
|
|
| EGFR-IN-173 |
|
|
|
|
|
| EGFR-IN-175 |
|
|
|
|
|
| EGFR-IN-176 |
|
|
|
|
|
| EGFR-IN-181 |
|
|
|
|
|
| EGFR-IN-182 |
|
|
|
|
|
| EGFR-IN-185 |
|
|
|
|
|
| EGFR-IN-191 |
|
|
|
|
|
| EGFR-IN-192 |
|
|
|
|
|
| EGFR-IN-196 |
|
|
|
|
|
| EGFR-IN-201 |
|
|
|
|
|
| EGFR-IN-209 |
|
|
|
|
|
| EGFR-IN-213 |
|
|
|
|
|
| EGFR-IN-214 |
|
|
|
|
|
| EGFR-IN-451 |
|
|
|
|
|
| EGFR/Akt-IN-1 |
|
|
|
|
|
| EGFR/tubulin-IN-1 |
|
|
|
|
|
| Egg oil |
|
|
|
|
99.0% |
| Engasertib |
|
|
|
|
99.65% |
| Ephemeranthol A |
|
|
|
|
|
| EpskA21 |
|
|
|
|
|
| ERBB agonist-1 |
|
|
|
|
99.16% |
| Eriocalyxin B |
|
|
|
|
99.93% |
| Erufosine |
|
|
|
|
|
| Ethyl linoleate |
|
|
|
|
99.72% |
| Etilefrine |
|
|
|
|
97.03% |
| Eudebeiolide B |
|
|
|
|
|
| FAK inhibitor 7 |
|
|
|
|
|
| FAK-IN-22 |
|
|
|
|
|
| FASN-IN-8 |
|
|
|
|
|
| FDW028 |
|
|
|
|
99.41% |
| Fenitrothion-d6 |
|
|
|
|
|
| FGF7p |
|
|
|
|
99.34% |
| FGFR-IN-23 |
|
|
|
|
|
| FGFR-IN-24 |
|
|
|
|
|
| FGFR-IN-25 |
|
|
|
|
|
| FGFR-IN-27 |
|
|
|
|
|
| FGFR-IN-28 |
|
|
|
|
|
| FGFR4-IN-23 |
|
|
|
|
|
| FHND5032 |
|
|
|
|
99.49% |
| FKL-137 |
|
|
|
|
|
| FLC-8 |
|
|
|
|
|
| FLT3-IN-32 hydrochloride |
|
|
|
|
|
| FLT3-IN-34 |
|
|
|
|
|
| FLT3-IN-36 |
|
|
|
|
|
| FLT3-IN-37 |
|
|
|
|
|
| FLT3-IN-41 |
|
|
|
|
|
| FPA-124 |
|
|
|
|
95% |
| FPDT |
|
|
|
|
|
| FTI-277 |
|
|
|
|
|
| FTI-277 TFA |
|
|
|
|
|
| FYJ-195 |
|
|
|
|
|
| FZ1 peptide |
|
|
|
|
99.92% |
| Galloylpaeoniflorin |
|
|
|
|
98.30% |
| Gamendazole |
|
|
|
|
99.44% |
| Gamma-glutamylcysteine ammonium |
|
|
|
|
|
| Ganglioside GT1b (bovine) ammonium |
|
|
|
|
98% |
| Ganglioside GT1b (porcine) ammonium |
|
|
|
|
98% |
| GC1118 |
|
|
|
|
99.22% |
| GE1111 |
|
|
|
|
95.73% |
| Gersizangitide |
|
|
|
|
97.16% |
| Ginkgo biloba extract |
|
|
|
|
|
| Ginsenoside F2 |
|
|
|
|
99.92% |
| Ginsenoside Rg4 |
|
|
|
|
99.94% |
| Globulol |
|
|
|
|
99.74% |
| Glycybenzofuran |
|
|
|
|
|
| Gomisin N |
|
|
|
|
99.94% |
| GSD-11 |
|
|
|
|
|
| GSK-690693 |
|
|
|
|
98.47% |
| GSK2110183 analog 1 |
|
|
|
|
|
| GSK2110183 analog 1 hydrochloride |
|
|
|
|
99.83% |
| GSK3182571 |
|
|
|
|
98.97% |
| GSK3β-peptide |
|
|
|
|
99.69% |
| GTx-134 |
|
|
|
|
|
| H-Ile-Lys-Val-Ala-Val-OH |
|
|
|
|
99.35% |
| HBF-0079 |
|
|
|
|
|
| HBS-101 |
|
|
|
|
99.59% |
| HDAC1-IN-14 |
|
|
|
|
|
| Heart-homing peptide |
|
|
|
|
|
| Heclin |
|
|
|
|
98.00% |
| Hecubine |
|
|
|
|
|
| Hematein |
|
|
|
|
59.09% |
| Hexamethylene bisacetamide |
|
|
|
|
99.56% |
| Hispidin |
|
|
|
|
99.85% |
| Histamine dihydrochloride |
|
|
|
|
99.92% |
| Histamine-13C5, 15N3 |
|
|
|
|
|
| Histamine-15N3 |
|
|
|
|
|
| Histamine-d4 |
|
|
|
|
|
| Hit 14 |
|
|
|
|
|
| HKB99 |
|
|
|
|
99.65% |
| HL-8 |
|
|
|
|
99.17% |
| HS-345 |
|
|
|
|
|
| HS-72 |
|
|
|
|
|
| Hu7691 |
|
|
|
|
99.91% |
| Hu7691 free base |
|
|
|
|
|
| HVH-2930 |
|
|
|
|
96.54% |
| Hyaluronic acid sodium (MW 200-1560) |
|
|
|
|
99.41% |
| Hyaluronic acid sodium (MW 800kDa) |
|
|
|
|
|
| Hyaluronic acid, low endotoxin |
|
|
|
|
|
| Hydroxyflutamide |
|
|
|
|
99.77% |
| Hypoglycemic agent 3 |
|
|
|
|
|
| HYS-072 |
|
|
|
|
|
| HZX-02-059 |
|
|
|
|
99.40% |
| I194496 |
|
|
|
|
98.52% |
| IBL-302 |
|
|
|
|
95.49% |
| Ifupinostat |
|
|
|
|
99.30% |
| IL13Rα2 D1 |
|
|
|
|
99.17% |
| IMC-EB10 |
|
|
|
|
98% |
| Imofinostat |
|
|
|
|
99.40% |
| Insulin Detemir |
|
|
|
|
95% |
| Insulin glargine |
|
|
|
|
≥95.0% |
| INY-03-041 |
|
|
|
|
99.74% |
| INY-03-041 trihydrochloride |
|
|
|
|
98.44% |
| INY-05-040 |
|
|
|
|
98.67% |
| Ipatasertib |
|
|
|
|
99.74% |
| Ipatasertib dihydrochloride |
|
|
|
|
99.19% |
| Ipatasertib tosylate |
|
|
|
|
|
| IPL344 |
|
|
|
|
|
| Iridin |
|
|
|
|
99.72% |
| Iruplinalkib |
|
|
|
|
99.62% |
| IS20 |
|
|
|
|
99.85% |
| Isoandrographolide |
|
|
|
|
98.34% |
| Isocannflavin B |
|
|
|
|
|
| Isocryptotanshinone |
|
|
|
|
98% |
| Isocucurbitacin B |
|
|
|
|
98.98% |
| Isoprocurcumenol |
|
|
|
|
95.41% |
| Isorhamnetin-3-O-glucoside |
|
|
|
|
99.96% |
| Itacnosertib |
|
|
|
|
99.06% |
| Itacnosertib hydrochloride |
|
|
|
|
99.43% |
| JAK2-IN-9 |
|
|
|
|
|
| JE-133 |
|
|
|
|
|
| JM1-24-3 |
|
|
|
|
|
| JZ19 |
|
|
|
|
|
| K-80003 |
|
|
|
|
98.83% |
| K-8012 |
|
|
|
|
99.51% |
| K882 |
|
|
|
|
|
| Kaempferol 3-O-(2G-glucosylrutinoside)-7-O-glucoside |
|
|
|
|
|
| Kazinol A |
|
|
|
|
97.0% |
| KD36 |
|
|
|
|
|
| Ki11502 |
|
|
|
|
99.30% |
| Kihadanin B |
|
|
|
|
|
| KIM-161 |
|
|
|
|
|
| KP372-1 |
|
|
|
|
99.5% |
| KRAS G12D-IN-37 |
|
|
|
|
|
| KRAS IN-44 |
|
|
|
|
|
| KRAS-IN-58 |
|
|
|
|
|
| KS-133 |
|
|
|
|
98.75% |
| KS-99 |
|
|
|
|
|
| KTC1101 |
|
|
|
|
98.09% |
| KU004 |
|
|
|
|
|
| Kushenol Z |
|
|
|
|
|
| L-Borneol 7-O-[β-D-apiofuranosyl-(1→6)]-β-D-glucopyranoside |
|
|
|
|
99.97% |
| L-Valine-d1 |
|
|
|
|
|
| L-Valine-d7 |
|
|
|
|
|
| L-Valine |
|
|
|
|
99.89% |
| L-Valine-1-13C |
|
|
|
|
99.75% |
| L-Valine-1-13C,15N |
|
|
|
|
|
| L-Valine-13C5 |
|
|
|
|
99.6% |
| L-Valine-13C5,15N |
|
|
|
|
99.64% |
| L-Valine-13C5,15N,d2 |
|
|
|
|
|
| L-Valine-13C5,15N,d8 |
|
|
|
|
|
| L-Valine-15N |
|
|
|
|
99.74% |
| L-Valine-15N,d8 |
|
|
|
|
|
| L-Valine-2-13C |
|
|
|
|
|
| L-Valine-d1 |
|
|
|
|
98.0% |
| L-Valine-d8 |
|
|
|
|
99.91% |
| Larixol |
|
|
|
|
95.52% |
| Larixyl acetate |
|
|
|
|
99.44% |
| Latanoprost acid |
|
|
|
|
98.77% |
| Lazertinib |
|
|
|
|
99.87% |
| Lazertinib mesylate |
|
|
|
|
99.85% |
| Lazertinib mesylate hydrate |
|
|
|
|
|
| LC-MG-10 |
|
|
|
|
|
| LCI40 |
|
|
|
|
|
| Lemairamin |
|
|
|
|
|
| Levomilnacipran |
|
|
|
|
|
| Levomilnacipran-d10 hydrochloride |
|
|
|
|
|
| LHQ766 |
|
|
|
|
|
| LIB3S0280 |
|
|
|
|
99.89% |
| Licoflavanone |
|
|
|
|
|
| Liensinine perchlorate |
|
|
|
|
99.67% |
| Link N peptide |
|
|
|
|
99.62% |
| Lixisenatide |
|
|
|
|
99.84% |
| LM22B-10 |
|
|
|
|
99.92% |
| Loliolide |
|
|
|
|
99.92% |
| LQEQ-19 (mouse, rat) |
|
|
|
|
|
| LT-1339-553 |
|
|
|
|
|
| Lumichrome-d8 |
|
|
|
|
|
| Lupenone |
|
|
|
|
99.74% |
| LY-2624587 |
|
|
|
|
|
| LYA914 |
|
|
|
|
|
| M2698 |
|
|
|
|
99.74% |
| M802 |
|
|
|
|
|
| MA191 |
|
|
|
|
|
| MARY1 |
|
|
|
|
|
| MARY15 |
|
|
|
|
99.97% |
| MCC1019 |
|
|
|
|
|
| Melafolone |
|
|
|
|
|
| Methoxyfenoterol |
|
|
|
|
|
| Methyl Eugenol |
|
|
|
|
99.79% |
| Methyl protodioscin |
|
|
|
|
99.67% |
| Miransertib |
|
|
|
|
99.32% |
| Miransertib hydrochloride |
|
|
|
|
99.74% |
| Miransertib mesylate |
|
|
|
|
|
| Mito-Esculetin |
|
|
|
|
|
| Mito-fisetin mF7 |
|
|
|
|
|
| MJ33 |
|
|
|
|
|
| MJ33 lithium salt |
|
|
|
|
99.0% |
| MK-2206 |
|
|
|
|
99.72% |
| MK-2206 dihydrochloride |
|
|
|
|
99.94% |
| MK-2206 free base |
|
|
|
|
|
| MKC-1 |
|
|
|
|
99.78% |
| ML-B01 |
|
|
|
|
|
| ML175 |
|
|
|
|
99.37% |
| MMP-9-IN-3 |
|
|
|
|
|
| MMP-9-IN-4 |
|
|
|
|
|
| MMP-9-IN-5 |
|
|
|
|
|
| Mocravimod |
|
|
|
|
98.39% |
| Mocravimod hydrochloride |
|
|
|
|
99.99% |
| Molephantin |
|
|
|
|
|
| Momordicine I |
|
|
|
|
97.0% |
| Monascuspiloin |
|
|
|
|
95% |
| Monomethyl lithospermate |
|
|
|
|
|
| Moracin G |
|
|
|
|
|
| MP-RM-1 |
|
|
|
|
96.29% |
| MRS2768 tetrasodium salt |
|
|
|
|
98.7% |
| MS143 |
|
|
|
|
|
| MS15 |
|
|
|
|
|
| MS15 TFA |
|
|
|
|
99.82% |
| MS170 |
|
|
|
|
98.68% |
| MS21 |
|
|
|
|
99.64% |
| MS5033 |
|
|
|
|
|
| MS98 |
|
|
|
|
|
| MT-125 |
|
|
|
|
98.73% |
| MT-125 free base |
|
|
|
|
98.67% |
| Multi-kinase-IN-2 |
|
|
|
|
|
| Multi-kinase-IN-7 |
|
|
|
|
|
| Musk ketone |
|
|
|
|
99.21% |
| Myrislignan |
|
|
|
|
99.53% |
| Myrislignan-13C,d2 |
|
|
|
|
|
| N-Acetyldehydroanonaine |
|
|
|
|
|
| N-Arachidonoyl-L-serine |
|
|
|
|
98% |
| N-Oleoyl glycine |
|
|
|
|
99.0% |
| N-Feruloyloctopamine |
|
|
|
|
99.91% |
| N-Hydroxyphthalimide |
|
|
|
|
99.63% |
| N6,N6-Dimethyladenosine |
|
|
|
|
99.66% |
| N6-Cyclohexyladenosine |
|
|
|
|
99.79% |
| NAP1051 |
|
|
|
|
|
| Naphthazarin |
|
|
|
|
99.59% |
| Nastorazepide |
|
|
|
|
99.95% |
| Nastorazepide hemicalcium |
|
|
|
|
|
| NBM-T-BMX-OS01 |
|
|
|
|
99.74% |
| NCT-501 |
|
|
|
|
99.59% |
| NCT-501 hydrochloride |
|
|
|
|
|
| NF-κB-IN-19 |
|
|
|
|
|
| NGI-189 |
|
|
|
|
99.29% |
| Nic-15 |
|
|
|
|
|
| Niloticin |
|
|
|
|
98.0% |
| NISC-6 |
|
|
|
|
|
| NL13 |
|
|
|
|
|
| NN3201 |
|
|
|
|
99.15% |
| Nogo-B-IN-1 |
|
|
|
|
|
| Notoginsenoside R4 |
|
|
|
|
99.34% |
| NPS 2390 |
|
|
|
|
99.90% |
| Nrf2/HO-1 activator 1 |
|
|
|
|
|
| Nrf2/HO-1 activator 2 |
|
|
|
|
|
| NS-417 free base |
|
|
|
|
|
| NSC 850745 |
|
|
|
|
|
| NSC126188 |
|
|
|
|
|
| NSC45586 |
|
|
|
|
|
| NSC45586 sodium |
|
|
|
|
98.0% |
| NSC47924 |
|
|
|
|
95.0% |
| NY0123 |
|
|
|
|
|
| Oleanolic acid 28-O-β-D-glucopyranoside |
|
|
|
|
99.42% |
| Oroselol |
|
|
|
|
|
| Osthenol |
|
|
|
|
99.15% |
| Ovalitenone |
|
|
|
|
|
| Oxaprozin-d10 |
|
|
|
|
|
| Oxypeucedanin |
|
|
|
|
99.50% |
| P1D-34 |
|
|
|
|
|
| Palmitoylcarnitine chloride |
|
|
|
|
98.0% |
| Pam2CSK4 |
|
|
|
|
|
| Pam2CSK4 TFA |
|
|
|
|
99.46% |
| pan-KRAS-IN-5 |
|
|
|
|
96.70% |
| Pan-RAS-IN-8 |
|
|
|
|
|
| PAV-174 |
|
|
|
|
|
| PD-1/PD-L1-IN-54 |
|
|
|
|
|
| PDGFRA/CAIX/XII-IN-1 |
|
|
|
|
98.10% |
| PDK1/Akt/Flt dual pathway inhibitor |
|
|
|
|
|
| Pegloxenatide |
|
|
|
|
90.00% |
| Peptide E5 |
|
|
|
|
|
| Peptide R54 acetate |
|
|
|
|
99.88% |
| PF-AKT400 |
|
|
|
|
98.0% |
| PH-064 |
|
|
|
|
98.78% |
| PH-064 (tetra(hydrochloride)) |
|
|
|
|
|
| Phoenixin-14 |
|
|
|
|
99.28% |
| Phoenixin-14 TFA |
|
|
|
|
|
| Phosphatidylserine |
|
|
|
|
98% |
| Phosphocreatine dipotassium |
|
|
|
|
|
| Phosphocreatine disodium hydrate |
|
|
|
|
99.57% |
| PHT-427 |
|
|
|
|
98.09% |
| PHT-427-d4 |
|
|
|
|
|
| Physalin A |
|
|
|
|
99.63% |
| PI3K-IN-29 |
|
|
|
|
|
| PI3K-IN-48 |
|
|
|
|
|
| PI3K-IN-56 |
|
|
|
|
|
| PI3K-IN-63 |
|
|
|
|
|
| PI3K-IN-7 |
|
|
|
|
|
| PI3K/AKT-IN-1 |
|
|
|
|
99.64% |
| PI3K/AKT-IN-2 |
|
|
|
|
98.10% |
| PI3K/AKT-IN-3 |
|
|
|
|
|
| PI3K/AKT-IN-4 |
|
|
|
|
|
| PI3K/AKT-IN-5 |
|
|
|
|
|
| PI3K/AKT-IN-6 |
|
|
|
|
|
| PI3K/Akt/CREB activator 1 |
|
|
|
|
98.64% |
| PI3K/AKT/ERK/CREB activator 1 |
|
|
|
|
|
| PI3K/Akt/mTOR-IN-2 |
|
|
|
|
99.93% |
| PI3K/Akt/mTOR-IN-3 |
|
|
|
|
|
| PI3K/Akt/mTOR-IN-4 |
|
|
|
|
|
| PI3K/Akt/mTOR-IN-5 |
|
|
|
|
|
| PI3K/Akt/mTOR-IN-6 |
|
|
|
|
|
| PI3K/Akt/mTOR-IN-7 |
|
|
|
|
|
| PI3K/HDAC-IN-4 |
|
|
|
|
|
| PI3K/mTOR-IN-22 |
|
|
|
|
|
| PI3Kα-IN-23 |
|
|
|
|
|
| PI3Kα-IN-28 |
|
|
|
|
|
| PI3Kα-IN-29 |
|
|
|
|
|
| PI3Kα-IN-30 |
|
|
|
|
|
| PI3Kα-IN-32 |
|
|
|
|
|
| PI3Kα-IN-33 |
|
|
|
|
|
| PI3Kδ-IN-10 |
|
|
|
|
|
| PI3Kδ-IN-11 |
|
|
|
|
|
| PI3Kδ-IN-24 |
|
|
|
|
|
| PI3Kδ-IN-25 |
|
|
|
|
|
| PI3Kδ-IN-28 |
|
|
|
|
|
| PI4KIII beta inhibitor 4 |
|
|
|
|
|
| Pifusertib |
|
|
|
|
99.81% |
| Pifusertib hydrochloride |
|
|
|
|
99.90% |
| Pipoxolan |
|
|
|
|
|
| PKM2/PDK1-IN-1 |
|
|
|
|
|
| PLAGL2-IN-1 |
|
|
|
|
|
| PLS-123 |
|
|
|
|
|
| Pongamol |
|
|
|
|
99.81% |
| PP2A Cancerous-IN-1 |
|
|
|
|
|
| PP30 |
|
|
|
|
98.01% |
| PPM-18 |
|
|
|
|
99.17% |
| PrCP-7414 |
|
|
|
|
|
| PRE-084 |
|
|
|
|
|
| PRE-084 hydrochloride |
|
|
|
|
99.92% |
| Propionyl-L-carnitine |
|
|
|
|
95.0% |
| PROTAC Akt3 Degrader-1 |
|
|
|
|
|
| PROTAC CB1R Degrader-1 |
|
|
|
|
|
| PROTAC FAK degrader 1 |
|
|
|
|
99.25% |
| PROTAC FAK degrader 2 |
|
|
|
|
|
| PROTAC FLT3/CHK1 Degrader-1 |
|
|
|
|
|
| PROTAC HER2 degrader-1 |
|
|
|
|
98.0% |
| PROTAC HIF-1α degrader-2 |
|
|
|
|
|
| PROTAC PI3K/110β degrader-2 |
|
|
|
|
|
| PROTAC PI3Kδ degrader-1 |
|
|
|
|
|
| PROTAC Sirt2 Degrader-2 |
|
|
|
|
|
| PROTAC TG2 Degrader-3 |
|
|
|
|
|
| Protectin D1 |
|
|
|
|
99.0% |
| PRT543 |
|
|
|
|
|
| PTD10 |
|
|
|
|
97.38% |
| Pterosin A |
|
|
|
|
94.07% |
| PTP1B-IN-24 |
|
|
|
|
98.46% |
| Puquitinib |
|
|
|
|
|
| PX-316 |
|
|
|
|
|
| Q-Peptide |
|
|
|
|
99.46% |
| Quinalizarin |
|
|
|
|
97.23% |
| Rac-ZINC4085554 |
|
|
|
|
|
| Rac1-IN-5 |
|
|
|
|
99.84% |
| Recilisib |
|
|
|
|
99.94% |
| Recilisib sodium |
|
|
|
|
|
| rel-Latanoprost acid |
|
|
|
|
|
| Reptoside |
|
|
|
|
99.92% |
| Revaprazan hydrochloride |
|
|
|
|
99.98% |
| Rhodiolin |
|
|
|
|
98% |
| Rizavasertib |
|
|
|
|
99.04% |
| RLX |
|
|
|
|
|
| RLX hydrochloride |
|
|
|
|
|
| ROCK2-IN-13 |
|
|
|
|
|
| ROR1-IN-3 |
|
|
|
|
|
| Royleanone |
|
|
|
|
|
| Sappanone A |
|
|
|
|
99.87% |
| SAR125844 |
|
|
|
|
98.17% |
| SB-699551 |
|
|
|
|
99.53% |
| SB-699551 free base |
|
|
|
|
|
| SBI-0640726 |
|
|
|
|
|
| SC66 |
|
|
|
|
99.65% |
| SC79 |
|
|
|
|
98.0% |
| Schisantherin B |
|
|
|
|
99.75% |
| Scoulerine hydrochloride |
|
|
|
|
|
| SCR1693 |
|
|
|
|
|
| Secologanic acid |
|
|
|
|
98.02% |
| Sennidin A |
|
|
|
|
|
| Sennidin B |
|
|
|
|
99.25% |
| SETDB1-TTD-IN-1 |
|
|
|
|
99.93% |
| Setidegrasib |
|
|
|
|
99.42% |
| SEW2871 |
|
|
|
|
99.88% |
| SH-5 |
|
|
|
|
|
| SH543 |
|
|
|
|
|
| Shinpterocarpin |
|
|
|
|
|
| SHIP1-IN-1 |
|
|
|
|
|
| SHP2 inhibitor LY6 |
|
|
|
|
|
| SHP2-IN-35 |
|
|
|
|
|
| SHP2-IN-47 |
|
|
|
|
|
| SHP2-IN-8 |
|
|
|
|
|
| SHR-A1403 Antibody |
|
|
|
|
|
| SHY-855 |
|
|
|
|
98.54% |
| SHY-867 |
|
|
|
|
|
| SIBP-03 |
|
|
|
|
|
| SIJ1777 |
|
|
|
|
|
| Sincalide |
|
|
|
|
99.30% |
| Sincalide ammonium |
|
|
|
|
99.21% |
| SIRT6-IN-3 |
|
|
|
|
98.19% |
| SJY26 |
|
|
|
|
|
| SKF-96365 |
|
|
|
|
99.97% |
| SKF-96365 hydrochloride |
|
|
|
|
99.93% |
| SKI-349 |
|
|
|
|
99.48% |
| SLC-391 |
|
|
|
|
|
| SM1-71-R |
|
|
|
|
|
| SMART1 |
|
|
|
|
99.87% |
| Solenopsin |
|
|
|
|
|
| SP6 |
|
|
|
|
|
| SPA0355 |
|
|
|
|
99.54% |
| SPOP-IN-1 |
|
|
|
|
99.71% |
| SQLE-IN-1 |
|
|
|
|
99.21% |
| SR 13668 |
|
|
|
|
|
| SS-3091 |
|
|
|
|
|
| SST0116CL1 |
|
|
|
|
|
| SST0116CL1 free base |
|
|
|
|
|
| ST-168 |
|
|
|
|
|
| ST6GAL1-IN-1 |
|
|
|
|
99.22% |
| STA-013 |
|
|
|
|
99.18% |
| STAT3/AKT-IN-1 |
|
|
|
|
|
| Stearamide |
|
|
|
|
97.0% |
| Strictinin |
|
|
|
|
97.15% |
| Strictosamide |
|
|
|
|
99.94% |
| SU6656 |
|
|
|
|
98.30% |
| Suberic acid |
|
|
|
|
98.0% |
| SY-LB-35 |
|
|
|
|
99.54% |
| Syringolin A |
|
|
|
|
|
| T133 |
|
|
|
|
|
| T3 Peptide |
|
|
|
|
|
| Tanerasertib |
|
|
|
|
99.42% |
| Tanshinol borneol ester |
|
|
|
|
|
| TAS0612 |
|
|
|
|
98.83% |
| TASP0415914 |
|
|
|
|
99.02% |
| TAT-N15 |
|
|
|
|
|
| TAT-TCL1-Akt-in |
|
|
|
|
|
| Taurolithocholic acid |
|
|
|
|
98.38% |
| Taurolithocholic acid sodium salt |
|
|
|
|
99.81% |
| Taurolithocholic acid-d4 |
|
|
|
|
98.36% |
| Taurolithocholic acid-d4 sodium |
|
|
|
|
99.4% |
| Taurolithocholic acid-d4-1 sodium |
|
|
|
|
|
| Taurolithocholic acid-d5 |
|
|
|
|
|
| Taurolithocholic Acid-d5 sodium |
|
|
|
|
|
| TB500 |
|
|
|
|
99.57% |
| TCL1(10-24) |
|
|
|
|
|
| TD52 |
|
|
|
|
95.0% |
| TD52 dihydrochloride |
|
|
|
|
99.55% |
| Tegafur-gimeracil-oteracil potassium |
|
|
|
|
99.96% |
| Theasaponin E1 |
|
|
|
|
99.08% |
| Tianeptine-d6 hydrochloride |
|
|
|
|
|
| Topo I/II-IN-2 |
|
|
|
|
|
| Tovophyllin A |
|
|
|
|
|
| Toyaburgine |
|
|
|
|
|
| trans-Isoferulic acid |
|
|
|
|
99.93% |
| Triciribine |
|
|
|
|
98.62% |
| Trilinolein |
|
|
|
|
98.0% |
| Trilinolein-13C54 |
|
|
|
|
|
| Trilinolein-d5 |
|
|
|
|
|
| Triphenyl phosphate-d15 |
|
|
|
|
99.55% |
| TRPM7-IN-1 |
|
|
|
|
98.83% |
| TSR-011-isomer |
|
|
|
|
|
| Tubulin-IN-55 |
|
|
|
|
|
| Tubulin-IN-64 |
|
|
|
|
|
| Tubulin/AKT1-IN-1 |
|
|
|
|
|
| TX2-121-1 |
|
|
|
|
|
| UCL-TRO-1938 |
|
|
|
|
99.98% |
| ULK1-IN-3 |
|
|
|
|
|
| Umckalin |
|
|
|
|
|
| UNC10013 |
|
|
|
|
99.90% |
| UNC1062 |
|
|
|
|
98.92% |
| UNC1666 |
|
|
|
|
|
| Uprosertib |
|
|
|
|
99.93% |
| Uprosertib hydrochloride |
|
|
|
|
|
| Urolithin M5 |
|
|
|
|
97.31% |
| Vasculotide |
|
|
|
|
99.84% |
| Vasculotide TFA |
|
|
|
|
99.88% |
| VEGFR-2-IN-77 |
|
|
|
|
|
| VEGFR-2/AKT-IN-1 |
|
|
|
|
|
| VEGFR-2/AKT-IN-2 |
|
|
|
|
|
| VEGFR2-IN-84 |
|
|
|
|
|
| Vevorisertib |
|
|
|
|
98.03% |
| Vevorisertib trihydrochloride |
|
|
|
|
99.13% |
| VJDT |
|
|
|
|
99.68% |
| VO-OHPic |
|
|
|
|
|
| VVD-442 |
|
|
|
|
99.97% |
| VVD-484 |
|
|
|
|
|
| VVD-699 |
|
|
|
|
99.83% |
| VVD-844 |
|
|
|
|
|
| VVD-849 |
|
|
|
|
99.76% |
| WB-308 |
|
|
|
|
|
| WCY-8-67 |
|
|
|
|
|
| WCY-8-67 TFA |
|
|
|
|
99.40% |
| WF-10129 |
|
|
|
|
|
| WH23 |
|
|
|
|
|
| Wighteone |
|
|
|
|
98.71% |
| Withangulatin A |
|
|
|
|
99.76% |
| WK88-1 |
|
|
|
|
|
| Wnt/β-catenin-IN-6 |
|
|
|
|
98.34% |
| Wortmannin-Rapamycin Conjugate 1 |
|
|
|
|
|
| WZH-17-002 |
|
|
|
|
|
| X-370 |
|
|
|
|
|
| Xaliproden free base |
|
|
|
|
|
| Xaliproden hydrochloride |
|
|
|
|
98.40% |
| XL-418 |
|
|
|
|
95.19% |
| XMU-MP-2 |
|
|
|
|
99.29% |
| XOMA-213 |
|
|
|
|
98.46% |
| Y-27632 |
|
|
|
|
99.46% |
| Y-27632 hydrochloride hydrate |
|
|
|
|
99.65% |
| YJ1206 |
|
|
|
|
97.26% |
| YJZ5118 |
|
|
|
|
|
| YK-8S |
|
|
|
|
|
| Yoda 1 |
|
|
|
|
99.97% |
| YS-49 |
|
|
|
|
99.98% |
| YS-49 monohydrate |
|
|
|
|
99.71% |
| Yuanhuadin |
|
|
|
|
|
| YVPGP |
|
|
|
|
|
| YW3-56 hydrochloride |
|
|
|
|
|
| Endoxifen (Z-isomer) |
|
|
|
|
99.19% |
| Endoxifen Z-isomer hydrochloride |
|
|
|
|
98.98% |
| Zandelisib |
|
|
|
|
99.67% |
| Zandelisib hydrochloride |
|
|
|
|
|
| Zaptuzumab |
|
|
|
|
99.0% |
| ZEB85 |
|
|
|
|
96.3985% |
| ZINC-1000507824 |
|
|
|
|
|
| ZINC00640089 |
|
|
|
|
99.76% |
| ZINC00784494 |
|
|
|
|
99.96% |
| ZLY06 |
|
|
|
|
98.75% |
| ZSH-2117 |
|
|
|
|
|
| α-D-Manp(3→1)-α-D-Manp(2→1)-α-D-Glu |
|
|
|
|
|
| α-Linolenic acid sodium |
|
|
|
|
96.66% |
| α-Santalol |
|
|
|
|
97.62% |
| α-Linolenic acid |
|
|
|
|
99.92% |
| α-Linolenic acid-13C18 |
|
|
|
|
99.5% |
| α-Linolenic acid-d14 |
|
|
|
|
|
| α-Linolenic acid-d5 |
|
|
|
|
97.80% |
| α-Solanine |
|
|
|
|
99.89% |
| Gamma-glutamylcysteine |
|
|
|
|
98.53% |
| Gamma-glutamylcysteine TFA |
|
|
|
|
96.68% |
| Syringaresinol |
|
|
|
|
99.66% |
| Notoginsenoside Ft1 |
|
|
|
|
99.49% |
| Triadimefon |
|
|
|
|
98.12% |
| Triadimefon (Standard) |
|
|
|
|
98.05% |
| Lixisenatide (Leu-13C6,15N) TFA |
|
|
|
|
|
| Deltonin |
|
|
|
|
99.93% |
| Eurycomalactone |
|
|
|
|
99.74% |
| Sericin |
|
|
|
|
0% |
| Salvianolic acid F |
|
|
|
|
99.30% |
| Ethalfluralin |
|
|
|
|
|
| Aceglutamide |
|
|
|
|
98.0% |
| Dihydrocapsaicin-d3 |
|
|
|
|
|
| Dihydrocapsaicin |
|
|
|
|
99.93% |
| Panaxatriol |
|
|
|
|
99.93% |
| High density lipoprotein (human) |
|
|
|
|
|
| Bacopaside I |
|
|
|
|
99.20% |
| Lumichrome |
|
|
|
|
99.84% |
| Crebanine |
|
|
|
|
99.83% |
| Clifutinib |
|
|
|
|
99.59% |
| Perfluoroundecanoic acid-13C7 |
|
|
|
|
|
| Perfluoroundecanoic acid |
|
|
|
|
99.85% |
| Perfluorotetradecanoic acid |
|
|
|
|
98.0% |
| Ponicidin |
|
|
|
|
99.93% |
| Oridonin |
|
|
|
|
99.89% |
| Ononin |
|
|
|
|
99.97% |
| Heptadecanoic acid |
|
|
|
|
99.90% |
| Monosialoganglioside GM3 (bovine) |
|
|
|
|
|
| Carebastine |
|
|
|
|
99.23% |
| Flavokawain A |
|
|
|
|
99.73% |
| Flavokawain C |
|
|
|
|
99.53% |
| Dehydrocostus Lactone |
|
|
|
|
99.98% |
| Deoxyandrographolide |
|
|
|
|
99.80% |
| Deferoxamine |
|
|
|
|
99.57% |
| Bisphenol A-13C12 |
|
|
|
|
96.38% |
| 4,4'-Sulfonyldiphenol |
|
|
|
|
99.44% |
| Bisphenol A |
|
|
|
|
99.91% |
| Indoprofen |
|
|
|
|
99.36% |
| Honokiol |
|
|
|
|
99.85% |
| Perifosine |
|
|
|
|
99.91% |
| Tianeptine-d12 |
|
|
|
|
|
| Tianeptine |
|
|
|
|
99.21% |
| Tianeptine sodium salt |
|
|
|
|
99.71% |
| Tioconazole |
|
|
|
|
99.90% |
| Tetrahydroalstonine |
|
|
|
|
99.84% |
| Tubeimoside I |
|
|
|
|
99.96% |
| Kukoamine B |
|
|
|
|
99.87% |
| Kukoamine B-d5 dihydrochloride |
|
|
|
|
|
| Kukoamine B mesylate |
|
|
|
|
|
| Etaracizumab |
|
|
|
|
99.81% |
| Doxepin |
|
|
|
|
99.66% |
| Doxycycline-d3 (hyclate) (major) |
|
|
|
|
|
| Soyasaponin Ba |
|
|
|
|
99.47% |
| Cefminox sodium |
|
|
|
|
99.83% |
| Kirenol |
|
|
|
|
99.82% |
| Oxaprozin |
|
|
|
|
99.94% |
| Oxaprozin potassium |
|
|
|
|
|
| Propylparaben sodium |
|
|
|
|
99.03% |
| Kazinol B |
|
|
|
|
|
| Propylparaben-d4 |
|
|
|
|
99.62% |
| Propylparaben-d7 |
|
|
|
|
|
| Urolithin B |
|
|
|
|
99.85% |
| Kaempferide |
|
|
|
|
99.80% |
| Hawthorn Extract |
|
|
|
|
|
| Batatasin III |
|
|
|
|
99.54% |
| Arnicolide D |
|
|
|
|
99.69% |
| Jolkinolide B |
|
|
|
|
99.65% |
| Jolkinolide B (Standard) |
|
|
|
|
|
| Asperosaponin VI |
|
|
|
|
99.62% |
| Levomilnacipran hydrochloride |
|
|
|
|
99.95% |
| Levomilnacipran-d5 hydrochloride |
|
|
|
|
|
| Isomaltulose monohydrate |
|
|
|
|
|
| Patritumab |
|
|
|
|
99.28% |
| Duligotuzumab |
|
|
|
|
99.17% |
| Isoscopoletin |
|
|
|
|
99.92% |
| Isorhapontigenin |
|
|
|
|
99.82% |
| Isoviolanthin |
|
|
|
|
99.87% |
| Isoacteoside |
|
|
|
|
99.73% |
| Isoginkgetin |
|
|
|
|
99.91% |
| Isoastragaloside I |
|
|
|
|
99.49% |
| Guaiazulene |
|
|
|
|
99.08% |
| Gomisin D |
|
|
|
|
99.56% |
| Dinitramine |
|
|
|
|
|
| Serplulimab |
|
|
|
|
99.30% |
| Acenocoumarol-d4 |
|
|
|
|
|
| Acenocoumarol-d5 |
|
|
|
|
|
| Acenocoumarol |
|
|
|
|
99.17% |
| Trimebutine |
|
|
|
|
99.42% |
| Trimebutine-d5 fumarate |
|
|
|
|
|
| Trimebutine-d3 hydrochloride |
|
|
|
|
|
| Tizanidine-d4 |
|
|
|
|
99.93% |
| Tizanidine |
|
|
|
|
99.58% |
| Tilorone |
|
|
|
|
99.80% |
| Epimedin A |
|
|
|
|
99.43% |
| Micheliolide |
|
|
|
|
99.77% |
| Fenitrothion |
|
|
|
|
99.43% |
| Pinoresinol Diglucoside |
|
|
|
|
99.84% |
| Tamarixetin |
|
|
|
|
98.80% |
| Phlorizin |
|
|
|
|
99.93% |
| Phlorizin dihydrate |
|
|
|
|
98.0% |
| (±)-Myrtenol |
|
|
|
|
95.0% |
| Kuwanon G |
|
|
|
|
99.45% |
| (+)-Medioresinol |
|
|
|
|
99.13% |
| Sophocarpine |
|
|
|
|
99.85% |
| Sophocarpine monohydrate |
|
|
|
|
99.91% |
| Darifenacin hydrobromide |
|
|
|
|
99.78% |
| Nickel(II) oxide |
|
|
|
|
|
| Cyanidin 3-sambubioside chloride |
|
|
|
|
98.40% |
| Zinc chloride, for cell culture |
|
|
|
|
|
| Lanthanum(Ⅲ) chloride |
|
|
|
|
99.99% |
| Delphinidin 3-glucoside chloride |
|
|
|
|
99.89% |
| Chloramphenicol |
|
|
|
|
99.96% |
| Threo-Chloramphenicol-d6 |
|
|
|
|
|
| Doxycycline monohydrate |
|
|
|
|
98.95% |
| Tabersonine |
|
|
|
|
98.02% |
| Tabersonine hydrochloride |
|
|
|
|
98.55% |
| Arenobufagin |
|
|
|
|
99.82% |
| Brassicasterol |
|
|
|
|
99.93% |
| Alisol B acetate |
|
|
|
|
|
| Tauroursodeoxycholate dihydrate |
|
|
|
|
99.96% |
| Vitexin-2"-O-rhamnoside |
|
|
|
|
99.78% |
| Vaccarin |
|
|
|
|
99.05% |
| Regaloside C |
|
|
|
|
99.62% |
| Ciprofloxacin hydrochloride monohydrate |
|
|
|
|
99.88% |
| Phellopterin |
|
|
|
|
99.94% |
| Revaprazan |
|
|
|
|
|
| Daphnetin |
|
|
|
|
99.77% |
| Polygalasaponin F |
|
|
|
|
99.85% |
| Licochalcone E |
|
|
|
|
98.07% |
| Licoricesaponin G2 |
|
|
|
|
99.87% |
| Licoricidin |
|
|
|
|
98.00% |
| Deferoxamine mesylate |
|
|
|
|
99.76% |
| Sorafenib tosylate |
|
|
|
|
99.98% |
| Beauvericin |
|
|
|
|
99.97% |
| Byakangelicol |
|
|
|
|
98.66% |
| Atractylenolide II |
|
|
|
|
99.89% |
| Bilobetin |
|
|
|
|
99.71% |
| Astringin |
|
|
|
|
98.97% |
| Thymoquinone |
|
|
|
|
99.80% |
| Vasicine hydrochloride |
|
|
|
|
98.62% |
| Etilefrine hydrochloride |
|
|
|
|
99.90% |
| Quinagolide hydrochloride |
|
|
|
|
99.55% |
| Doxazosin hydrochloride |
|
|
|
|
|
| Doxycycline-d3 hydrochloride |
|
|
|
|
|
| Ligustrazine hydrochloride |
|
|
|
|
99.93% |
| Penehyclidine hydrochloride |
|
|
|
|
99.2% |
| Tizanidine hydrochloride |
|
|
|
|
99.93% |
| Tizanidine-d4 hydrochloride |
|
|
|
|
|
| Ciprofloxacin monohydrochloride |
|
|
|
|
99.90% |
| Benazepril hydrochloride |
|
|
|
|
99.96% |
| Benazepril-d5 hydrochloride |
|
|
|
|
|
| Phellodendrine chloride |
|
|
|
|
99.68% |
| Berberine hemisulfate |
|
|
|
|
99.63% |
| Triphenyl phosphate |
|
|
|
|
98.0% |
| Phosphocreatine |
|
|
|
|
99.60% |
| Phosphocreatine disodium |
|
|
|
|
98.0% |
| Esculetin |
|
|
|
|
99.79% |
| Raddeanin A |
|
|
|
|
98.68% |
| Midostaurin-d5 |
|
|
|
|
98.0% |
| Miltefosine |
|
|
|
|
99.92% |
| Miltefosine-d4 |
|
|
|
|
|
| Sorafenib |
|
|
|
|
99.84% |
| Perillyl alcohol |
|
|
|
|
95.46% |
| Sequoyitol |
|
|
|
|
98.0% |
| Histamine |
|
|
|
|
99.99% |
| Histamine phosphate |
|
|
|
|
99.34% |
| Gynostemma Extract |
|
|
|
|
99.92% |
| Veligrotug |
|
|
|
|
99.25% |
| Rohitukine |
|
|
|
|
|
| Hydroxy celecoxib |
|
|
|
|
98.71% |
| Propylparaben |
|
|
|
|
99.96% |
| Voacamine |
|
|
|
|
99.64% |
| Polyporenic acid C |
|
|
|
|
98.81% |
| Cinnamyl Alcohol |
|
|
|
|
98.58% |
| Cinnamyl Alcohol-d5 |
|
|
|
|
|
| Cinnamyl Alcohol-d9 |
|
|
|
|
|
| Cholesta-3,5-diene |
|
|
|
|
99.54% |
| Lipoteichoic acid |
|
|
|
|
|
| Dehydroandrographolide succinate |
|
|
|
|
99.34% |
| Icrucumab |
|
|
|
|
99.9% |
| 1-Formyl-beta-carboline |
|
|
|
|
99.27% |
| Sulfabenzamide |
|
|
|
|
99.68% |
| Sulfabenzamide-d4 |
|
|
|
|
99.74% |
| Solanesol |
|
|
|
|
98.0% |
| Alizarin |
|
|
|
|
99.48% |
| Pachymic acid |
|
|
|
|
99.94% |
| Skimmianine |
|
|
|
|
99.90% |
| Atranorin |
|
|
|
|
99.68% |
| Curzerenone |
|
|
|
|
98.55% |
| Liensinine |
|
|
|
|
99.97% |
| Liensinine Diperchlorate |
|
|
|
|
99.96% |
| Fusaric acid |
|
|
|
|
99.94% |
| Jervine hydriodide |
|
|
|
|
|
| Glaucocalyxin A |
|
|
|
|
99.88% |
| Cranberry Extract |
|
|
|
|
|
| Gambogic amide |
|
|
|
|
95.76% |
| Bakkenolide A |
|
|
|
|
99.99% |
| Resibufogenin |
|
|
|
|
99.93% |
| Dracorhodin perchlorate |
|
|
|
|
99.02% |
| Isobavachalcone |
|
|
|
|
98.99% |
| Bavachalcone |
|
|
|
|
99.90% |
| Sipeimine |
|
|
|
|
98.57% |
| Plantamajoside |
|
|
|
|
99.80% |
| Coenzyme Q0 |
|
|
|
|
99.79% |
| Darifenacin |
|
|
|
|
99.81% |
| Telocinobufagin |
|
|
|
|
99.50% |
| Polygalacin D3 |
|
|
|
|
|
| Hyaluronic acid-BSA |
|
|
|
|
|
| Hyaluronic acid |
|
|
|
|
|
| Hyaluronic acid sodium |
|
|
|
|
98.0% |
| Tenacissoside H |
|
|
|
|
99.89% |
| Dipentyl phthalate |
|
|
|
|
99.5% |
| Tyroserleutide hydrochloride |
|
|
|
|
99.92% |
| Jujuboside B |
|
|
|
|
99.92% |
| Physalin B |
|
|
|
|
97.20% |
| Lixisenatide acetate |
|
|
|
|
99.11% |
| Paris saponin VII |
|
|
|
|
99.84% |
| Polyphyllin I |
|
|
|
|
99.91% |
| Scutellarin |
|
|
|
|
99.57% |
| Scoulerine |
|
|
|
|
99.99% |
| Rotundic acid |
|
|
|
|
98.41% |
| Afatinib |
|
|
|
|
99.92% |
| Afatinib dimaleate |
|
|
|
|
99.74% |
| Psicose |
|
|
|
|
99.90% |
| Artemisinin |
|
|
|
|
98.0% |
| Artemisinin-d3 |
|
|
|
|
|
| Artemisinin-13C,d4 |
|
|
|
|
|
| Hederacolchiside A1 |
|
|
|
|
98.0% |
| Guggulsterone |
|
|
|
|
99.78% |
| Typhaneoside |
|
|
|
|
99.74% |
| Trimebutine maleate |
|
|
|
|
99.66% |
| Deguelin |
|
|
|
|
99.20% |
| Lumretuzumab |
|
|
|
|
≥99.0% |
| Vasicine |
|
|
|
|
98.80% |
| Ergothioneine |
|
|
|
|
99.98% |
| Flavokawain B |
|
|
|
|
99.99% |
| Xanthosine |
|
|
|
|
99.99% |
| Cyclovirobuxine D |
|
|
|
|
99.70% |
| Phellodendrine |
|
|
|
|
|
| Actein |
|
|
|
|
99.58% |
| Xanthosine dihydrate |
|
|
|
|
|
| Coptisine |
|
|
|
|
|
| Coptisine Sulfate |
|
|
|
|
99.37% |
| Berberine |
|
|
|
|
|
| Berberine sulfate |
|
|
|
|
99.23% |
| Veratramine |
|
|
|
|
99.88% |
| Sinigrin |
|
|
|
|
99.92% |
| Sinigrin hydrate |
|
|
|
|
99.92% |
| Bellidifolin |
|
|
|
|
99.74% |
| Loureirin A |
|
|
|
|
99.96% |